Avricore Health (AVCRF) Net Income towards Common Stockholders (2009 - 2025)
Avricore Health (AVCRF) posted quarterly Net Income towards Common Stockholders of -$275603.9 for Q3 2025, down 110.02% YoY from $2.8 million in Q3 2024, and up 16.8% sequentially from -$331271.8 in Q2 2025.
Avricore Health (AVCRF) Net Income towards Common Stockholders (2009 - 2025) Analysis & Trends
Avricore Health has disclosed Net Income towards Common Stockholders across 16 years of filings, most recently posting -$275603.9 for Q3 2025.
- In Q3 2025, Net Income towards Common Stockholders fell 110.02% year-over-year to -$275603.9; the TTM figure through Dec 2025 stood at -$660790.6 (down 2081.76% YoY), while the FY2025 annual figure was $179230.2, up 136.68% from the prior year.
- Net Income towards Common Stockholders grew to -$275603.9 in Q3 2025, from -$331271.8 in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for AVCRF reached as high as $2.4 million in Q4 2021 and fell as low as -$390957.4 in Q3 2021.
- The 5-year median for Net Income towards Common Stockholders is $7215.0 (2022), against an average of $258155.3.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders surged 91317955.07% — and 2025, when it slumped 938.71%.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $2.4 million in 2021, then sank by 42.43% to $1.4 million in 2022, then slumped by 73.71% to $369002.7 in 2023, then plunged by 135.56% to -$131227.6 in 2024, then tumbled by 110.02% to -$275603.9 in 2025.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$275603.9, -$331271.8, and -$53914.9 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 141.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -35,788.23 |
| Jun 30, 2025 | -31,914.13 |
| Sep 30, 2024 | 318,731.62 |
| Jun 30, 2024 | 271,088.64 |
| Dec 31, 2023 | 369,002.74 |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2021 | -390,957.42 |
| Dec 31, 2015 | 0.01 |
| Sep 30, 2015 | 0.01 |
| Jun 30, 2015 | 1,788.60 Bn |
| Mar 31, 2015 | -0.01 |
| Dec 31, 2014 | -0.01 |
| Sep 30, 2014 | -0.01 |
| Jun 30, 2014 | -0.01 |
| Mar 31, 2014 | -0.01 |
| Dec 31, 2013 | -0.01 |
| Sep 30, 2013 | 0.01 |
| Jun 30, 2013 | -0.04 |
| Sep 30, 2012 | 0.12 |
| Jun 30, 2012 | 0.08 |